# A New Application of Amiloride in the Treatment of Patient With Chronic Kidney Disease In Reducing Urinary PROtein

> **NCT03170336** · PHASE4 · COMPLETED · sponsor: **Guangdong Provincial People's Hospital** · enrollment: 40 (actual)

## Conditions studied

- Chronic Kidney Diseases

## Interventions

- **DRUG:** Amiloride
- **DRUG:** Hydrochlorothiazide

## Key facts

- **NCT ID:** NCT03170336
- **Lead sponsor:** Guangdong Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-01
- **Primary completion:** 2020-08-01
- **Final completion:** 2020-08-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03170336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03170336, "A New Application of Amiloride in the Treatment of Patient With Chronic Kidney Disease In Reducing Urinary PROtein". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03170336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*